Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Niaz Khasanov"'
Autor:
Dilyara Khastieva, Niaz Khasanov
Publikováno v:
Russian Journal of Cardiology. 27:4962
A number of studies have demonstrated the negative impact of iron deficiency (ID) on the prognosis and course of heart failure. The prevalence of patients with coronary artery disease (CAD) in these studies was 39,4-65%, while the proportion of patie
Autor:
Niaz Khasanov
Publikováno v:
Russian Journal of Cardiology. 26:4807
In the EMPA-REG OUTCOME, CANVAS and DECLARE-TIMI 58 studies, in patients with type 2 diabetes and established cardiovascular diseases or risk factors, a decrease in the risk of cardiovascular events and development or worsening of heart failure cours
Autor:
Gilmar Reis, Rosa Pando, Igor Kaidashev, Niaz Khasanov, Maria Christiane Valeria Braga Braile-Sternieri, Oleksii Korzh, JOSE VILELA-MARTIN, Nick West, Marco Vugman Wainstein, Massimo Volpe, Thomas Pieber, Adam Tabak, Boris Mankovsky, Vadym Berenfus, Daniel Piskorz, Legkonogov Aleksandr, Ponnusamy Saravanan, Yury Shvarts, José Gerardo González-González, Hugo Laviada, Dragan Djordjevic, Giuseppe Derosa, Juhani Airaksinen, Russell Scott, Simon Heller, Boris Vesga, Marianna Janion, SRIKANTH BELLARY, Filipa Costa, Tristan Richardson, Anthony Guimaraes, Rogério Eduardo Gomes Sarmento Leite, John Wilding, SANTIAGO TOFÉ, Konstantin Nikolaev, Bernard Van Beers, Meyer ELBAZ, Eduardo Costa Duarte Barbosa, Olga Reshetko, Milan Pavlović, Yuriy Mostovoy, Zurkurnai Yusof, Stefano Genovese, Matthew Budoff, Tudor Poerner, Andriy Bazylevych, Mirela Cleopatra Tomescu, Yuriy Sirenko, Arsen Ristic, Elena Shutemova, DAVID GALVEZ CABALLERO, Addison Taylor, Jurisic-Erzen Dubravka, Luigi Gnudi, Iurii Rudyk
Publikováno v:
New England Journal of Medicine. 369(14):1327-1335
A b s t r ac t Background To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new a